{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:10:54Z","timestamp":1778598654336,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors that originate from neuroendocrine cells. They are common in the digestive system (such as the stomach, intestines, and pancreas) and the respiratory system, but they are rare in the urinary system, comprising less than 1%\u20132% of urinary malignancies. These tumors typically lack specific clinical symptoms and are usually diagnosed through postoperative pathological examinations. Due to their rarity, the clinical awareness of NENs remains insufficient in the community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data of 10 patients diagnosed with urinary tract neuroendocrine neoplasms (UT-NENs) were retrospectively collected and analyzed. We summarized their clinical characteristics and treatment outcomes, with the aim to improve our understanding of urinary tract NENs and further optimize personalized therapeutic strategies for these rare tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>In our study, 4 out of 10 patients were admitted for hematuria. Seven out of 10 patients had lesions in the bladder. Five of 6 cases with NEN muscularis propria invasion occurred in the bladder. All 3 deceased patients had bladder NEN. None of them received postoperative radiotherapy and chemotherapy. Five out of 6 surviving patients received postoperative radiotherapy and chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hematuria is the main symptom in UT-NENs. The bladder is the most common location of UT-NENs, while bladder lesions are more likely to present as poorly-differentiated neuroendocrine carcinoma. In the present case series, patients who received postoperative radiotherapy and chemotherapy showed a trend toward better long-term prognosis and survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1816850","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:25:35Z","timestamp":1777868735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A case series of primary urinary tract neuroendocrine neoplasms"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meikai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Reproductive Medicine Center of Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benkang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaofeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Qilu hospital of Shandong University","place":["Jinan, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1159\/000183751","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biotherapy","volume":"90","author":"Kjell","year":"2009","journal-title":"Neuroendocrinology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.anndiagpath.2019.06.009","article-title":"Neuroendocrine tumors of genitourinary tract: recent advances","volume":"42","author":"Shehabeldin","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0B013E3181EC124E","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"B5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/J.CLGC.2023.02.009","article-title":"Urinary neuroendocrine neoplasms treated in the \u201cmodern era\u201d: a multicenter retrospective review","volume":"21","author":"Le","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152788","article-title":"Clinicopathologic features of the ureteral neuroendocrine tumors","volume":"216","author":"Wang","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3346\/jkms.2001.16.6.796","article-title":"Small cell carcinoma of the ureter with squamous cell and transitional cell carcinomatous components associated with ureteral stone","volume":"16","author":"Kim","year":"2001","journal-title":"J Korean Med Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.12998\/WJCC.V10.I17.5884","article-title":"Primary renal small cell carcinoma: a case report","volume":"10","author":"Xie","year":"2022","journal-title":"World J Clin cases"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3899","article-title":"Neuroendocrine carcinoma of the ureter: a case report and literature review","volume":"11","author":"Wei","year":"2016","journal-title":"Oncol Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADCR.2022.07.065","article-title":"A case of primary small cell neuroendocrine carcinoma of the uterus","volume":"17","author":"Taku","year":"2022","journal-title":"Radiol Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.783","article-title":"Papillary adenocarcinoma of the renal pelvis with renal calculus: a rare case report","volume":"4","author":"Jianlong","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2015.1027194","article-title":"Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer","volume":"15","author":"Marzese","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0106-RS","article-title":"Primary neuroendocrine tumors of the ureter: a short review","volume":"140","author":"Acosta","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62369-3","article-title":"Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma","volume":"166","author":"Cheng","year":"2005","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.03.007","article-title":"Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of Malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma","volume":"4","author":"Priemer","year":"2017","journal-title":"Eur Urol Focus"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1757","article-title":"Small cell neuroendocrine carcinoma of the ureter: a case report and literature review","volume":"7","author":"Hai","year":"2014","journal-title":"Oncol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S364545","article-title":"Clinical and pathological features of primary renal well-differentiated neuroendocrine tumor","volume":"15","author":"Hua","year":"2022","journal-title":"OncoTargets Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.12.005","article-title":"Small cell carcinoma of the upper urinary tract (UUT-SCC): report of a rare entity and systematic review of the literature","volume":"37","author":"Ouzzane","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1006\/frne.2001.0218","article-title":"Neuroendocrine tumor markers","volume":"22","author":"Lamberts","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S138769","article-title":"Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature","volume":"10","author":"Zhong","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5812\/iranjradiol.4779","article-title":"Urography and CT features of primary small cell carcinoma of the ureter: a case report","volume":"10","author":"Jianfeng","year":"2013","journal-title":"Iranian J Radiology: A Q J Published by Iranian Radiological Soc"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10840","article-title":"Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract","volume":"95","author":"Burkhard","year":"2002","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/978-3-540-85516-3_114","article-title":"Multicentric small cell neuroendocrine neoplasm of the renal pelvis and ureter with concomitant focal high-grade urothelial carcinoma of the ureter: a case report","volume":"24","author":"John","year":"2008","journal-title":"Indian J Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5795\/jjscc.45.162","article-title":"Urothelial carcinoma of ureter with neuroendocrine differentiation: a case report","volume":"54","author":"Takahiko","year":"2008","journal-title":"Hinyokika Kiyo Acta Urologica Japonica"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJSCR.2023.108708","article-title":"Ureteral small cell neuroendocrine carcinoma: a case report and short review","volume":"111","author":"Wahjoe","year":"2023","journal-title":"Int J Surg Case Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1816850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:36:26Z","timestamp":1778596586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1816850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1816850"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1816850","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1816850"}}